Prosensa Wins Scrip ‘Biotech Company of the Year’ 2014 Award

10-Dec-2014 - Netherlands
Prosensa Holding N.V. has won the Scrip ‘Biotech Company of the Year’ Award for 2014. The Scrip Awards provide an opportunity to acknowledge and applaud the highest achievers across the biotechnology and pharmaceutical industry, recognizing both corporate and individual accomplishments. The award for ‘Biotech Company of the Year’ is given to the company which has demonstrated the greatest achievements for the year.
Hans Schikan, CEO of Prosensa, said, “Winning Scrip’s ‘Biotech Company of the Year’ Award is a great honor and a testament to the dedication and hard work of the Prosensa team.  Our drive to succeed is fueled by patients and their families, who continue to inspire us to make innovative therapies available as quickly and efficiently as possible.”
The other five finalists were: Ablynx; Horizon Discovery; Isis Pharmaceuticals; Mesoblast; and Silence Therapeutics.

Other news from the department business & finance

Most read news

More news from our other portals

Recognise, understand, heal: The World of Diagnostics